APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nifedipine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Nifedipine Market Analysis and Forecast 2026-2032

22 December 2025192 pages

Choose your research edition.

Industry ResearchNifedipine Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Nifedipine Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Nifedipine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nifedipine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Nifedipine Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Nifedipine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Nifedipine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Nifedipine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Nifedipine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Nifedipine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Nifedipine include Actavis, Bayer, Honglin Pharmaceutical, Huanghai, Pfizer, Lifeon Pharmaceutical, Teva, Simcere and Shyndec, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Nifedipine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Nifedipine, also provides the sales of main regions and countries. Of the upcoming market potential for Nifedipine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Nifedipine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Nifedipine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Nifedipine sales, projected growth trends, production technology, application and end-user industry.

Nifedipine Segment by Company

Actavis

Bayer

Honglin Pharmaceutical

Huanghai

Pfizer

Lifeon Pharmaceutical

Teva

Simcere

Shyndec

Yabao

ApicHope

EASEHEAL Pharmaceutical

Nifedipine Segment by Type

Nifedipine Controlled Release Tablets

Nifedipine Extended Action Tablets

Nifedipine Segment by Application

Hypertension

Heart Disease

Other

Nifedipine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nifedipine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nifedipine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nifedipine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Nifedipine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Nifedipine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nifedipine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Nifedipine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Nifedipine Controlled Release Tablets Major Manufacturers Table 3. Nifedipine Extended Action Tablets Major Manufacturers Table 4. Global Nifedipine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hypertension Major Manufacturers Table 6. Heart Disease Major Manufacturers Table 7. Other Major Manufacturers Table 8. Nifedipine Industry Trends Table 9. Nifedipine Industry Drivers Table 10. Nifedipine Industry Opportunities and Challenges Table 11. Nifedipine Industry Restraints Table 12. Global Nifedipine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Nifedipine Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Nifedipine Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Nifedipine Revenue Market Share by Region (2021-2026) Table 16. Global Nifedipine Revenue Market Share by Region (2027-2032) Table 17. Global Nifedipine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (tons) Table 18. Global Nifedipine Sales by Region (2021-2026) & (tons) Table 19. Global Nifedipine Sales by Region (2027-2032) & (tons) Table 20. Global Nifedipine Sales Market Share by Region (2021-2026) Table 21. Global Nifedipine Sales Market Share by Region (2027-2032) Table 22. Global Nifedipine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Nifedipine Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Nifedipine Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Nifedipine Sales Market Share by Manufacturers (2021-2026) Table 26. Global Nifedipine Sales Price (US$/kg) of Manufacturers (2021-2026) Table 27. Global Nifedipine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Nifedipine Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Nifedipine Manufacturers, Product Type & Application Table 30. Global Nifedipine Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Nifedipine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Nifedipine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Nifedipine Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Nifedipine Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Nifedipine Revenue Market Share by Type (2021-2026) Table 37. Global Nifedipine Revenue Market Share by Type (2027-2032) Table 38. Global Nifedipine Sales by Type 2021 VS 2025 VS 2032 (tons) Table 39. Global Nifedipine Sales by Type (2021-2026) & (tons) Table 40. Global Nifedipine Sales by Type (2027-2032) & (tons) Table 41. Global Nifedipine Sales Market Share by Type (2021-2026) Table 42. Global Nifedipine Sales Market Share by Type (2027-2032) Table 43. Global Nifedipine Price by Type (2021-2026) & (US$/kg) Table 44. Global Nifedipine Price by Type (2027-2032) & (US$/kg) Table 45. Global Nifedipine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Nifedipine Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Nifedipine Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Nifedipine Revenue Market Share by Application (2021-2026) Table 49. Global Nifedipine Revenue Market Share by Application (2027-2032) Table 50. Global Nifedipine Sales by Application 2021 VS 2025 VS 2032 (tons) Table 51. Global Nifedipine Sales by Application (2021-2026) & (tons) Table 52. Global Nifedipine Sales by Application (2027-2032) & (tons) Table 53. Global Nifedipine Sales Market Share by Application (2021-2026) Table 54. Global Nifedipine Sales Market Share by Application (2027-2032) Table 55. Global Nifedipine Price by Application (2021-2026) & (US$/kg) Table 56. Global Nifedipine Price by Application (2027-2032) & (US$/kg) Table 57. Actavis Company Information Table 58. Actavis Business Overview Table 59. Actavis Nifedipine Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 60. Actavis Nifedipine Product Portfolio Table 61. Actavis Recent Development Table 62. Bayer Company Information Table 63. Bayer Business Overview Table 64. Bayer Nifedipine Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 65. Bayer Nifedipine Product Portfolio Table 66. Bayer Recent Development Table 67. Honglin Pharmaceutical Company Information Table 68. Honglin Pharmaceutical Business Overview Table 69. Honglin Pharmaceutical Nifedipine Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 70. Honglin Pharmaceutical Nifedipine Product Portfolio Table 71. Honglin Pharmaceutical Recent Development Table 72. Huanghai Company Information Table 73. Huanghai Business Overview Table 74. Huanghai Nifedipine Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 75. Huanghai Nifedipine Product Portfolio Table 76. Huanghai Recent Development Table 77. Pfizer Company Information Table 78. Pfizer Business Overview Table 79. Pfizer Nifedipine Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 80. Pfizer Nifedipine Product Portfolio Table 81. Pfizer Recent Development Table 82. Lifeon Pharmaceutical Company Information Table 83. Lifeon Pharmaceutical Business Overview Table 84. Lifeon Pharmaceutical Nifedipine Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 85. Lifeon Pharmaceutical Nifedipine Product Portfolio Table 86. Lifeon Pharmaceutical Recent Development Table 87. Teva Company Information Table 88. Teva Business Overview Table 89. Teva Nifedipine Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 90. Teva Nifedipine Product Portfolio Table 91. Teva Recent Development Table 92. Simcere Company Information Table 93. Simcere Business Overview Table 94. Simcere Nifedipine Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 95. Simcere Nifedipine Product Portfolio Table 96. Simcere Recent Development Table 97. Shyndec Company Information Table 98. Shyndec Business Overview Table 99. Shyndec Nifedipine Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 100. Shyndec Nifedipine Product Portfolio Table 101. Shyndec Recent Development Table 102. Yabao Company Information Table 103. Yabao Business Overview Table 104. Yabao Nifedipine Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 105. Yabao Nifedipine Product Portfolio Table 106. Yabao Recent Development Table 107. ApicHope Company Information Table 108. ApicHope Business Overview Table 109. ApicHope Nifedipine Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 110. ApicHope Nifedipine Product Portfolio Table 111. ApicHope Recent Development Table 112. EASEHEAL Pharmaceutical Company Information Table 113. EASEHEAL Pharmaceutical Business Overview Table 114. EASEHEAL Pharmaceutical Nifedipine Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 115. EASEHEAL Pharmaceutical Nifedipine Product Portfolio Table 116. EASEHEAL Pharmaceutical Recent Development Table 117. North America Nifedipine Revenue by Type (2021-2026) & (US$ Million) Table 118. North America Nifedipine Revenue by Type (2027-2032) & (US$ Million) Table 119. North America Nifedipine Sales by Type (2021-2026) & (tons) Table 120. North America Nifedipine Sales by Type (2027-2032) & (tons) Table 121. North America Nifedipine Sales Price by Type (2021-2026) & (US$/kg) Table 122. North America Nifedipine Sales Price by Type (2027-2032) & (US$/kg) Table 123. North America Nifedipine Revenue by Application (2021-2026) & (US$ Million) Table 124. North America Nifedipine Revenue by Application (2027-2032) & (US$ Million) Table 125. North America Nifedipine Sales by Application (2021-2026) & (tons) Table 126. North America Nifedipine Sales by Application (2027-2032) & (tons) Table 127. North America Nifedipine Sales Price by Application (2021-2026) & (US$/kg) Table 128. North America Nifedipine Sales Price by Application (2027-2032) & (US$/kg) Table 129. North America Nifedipine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. North America Nifedipine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 131. North America Nifedipine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 132. North America Nifedipine Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 133. North America Nifedipine Sales by Country (2021-2026) & (tons) Table 134. North America Nifedipine Sales by Country (2027-2032) & (tons) Table 135. North America Nifedipine Sales Price by Country (2021-2026) & (US$/kg) Table 136. North America Nifedipine Sales Price by Country (2027-2032) & (US$/kg) Table 137. United States Nifedipine Revenue (2021-2032) & (US$ Million) Table 138. Canada Nifedipine Revenue (2021-2032) & (US$ Million) Table 139. Mexico Nifedipine Revenue (2021-2032) & (US$ Million) Table 140. Europe Nifedipine Revenue by Type (2021-2026) & (US$ Million) Table 141. Europe Nifedipine Revenue by Type (2027-2032) & (US$ Million) Table 142. Europe Nifedipine Sales by Type (2021-2026) & (tons) Table 143. Europe Nifedipine Sales by Type (2027-2032) & (tons) Table 144. Europe Nifedipine Sales Price by Type (2021-2026) & (US$/kg) Table 145. Europe Nifedipine Sales Price by Type (2027-2032) & (US$/kg) Table 146. Europe Nifedipine Revenue by Application (2021-2026) & (US$ Million) Table 147. Europe Nifedipine Revenue by Application (2027-2032) & (US$ Million) Table 148. Europe Nifedipine Sales by Application (2021-2026) & (tons) Table 149. Europe Nifedipine Sales by Application (2027-2032) & (tons) Table 150. Europe Nifedipine Sales Price by Application (2021-2026) & (US$/kg) Table 151. Europe Nifedipine Sales Price by Application (2027-2032) & (US$/kg) Table 152. Europe Nifedipine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 153. Europe Nifedipine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 154. Europe Nifedipine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 155. Europe Nifedipine Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 156. Europe Nifedipine Sales by Country (2021-2026) & (tons) Table 157. Europe Nifedipine Sales by Country (2027-2032) & (tons) Table 158. Europe Nifedipine Sales Price by Country (2021-2026) & (US$/kg) Table 159. Europe Nifedipine Sales Price by Country (2027-2032) & (US$/kg) Table 160. Germany Nifedipine Revenue (2021-2032) & (US$ Million) Table 161. France Nifedipine Revenue (2021-2032) & (US$ Million) Table 162. U.K. Nifedipine Revenue (2021-2032) & (US$ Million) Table 163. Italy Nifedipine Revenue (2021-2032) & (US$ Million) Table 164. Russia Nifedipine Revenue (2021-2032) & (US$ Million) Table 165. Spain Nifedipine Revenue (2021-2032) & (US$ Million) Table 166. Netherlands Nifedipine Revenue (2021-2032) & (US$ Million) Table 167. Switzerland Nifedipine Revenue (2021-2032) & (US$ Million) Table 168. Sweden Nifedipine Revenue (2021-2032) & (US$ Million) Table 169. Poland Nifedipine Revenue (2021-2032) & (US$ Million) Table 170. China Nifedipine Revenue by Type (2021-2026) & (US$ Million) Table 171. China Nifedipine Revenue by Type (2027-2032) & (US$ Million) Table 172. China Nifedipine Sales by Type (2021-2026) & (tons) Table 173. China Nifedipine Sales by Type (2027-2032) & (tons) Table 174. China Nifedipine Sales Price by Type (2021-2026) & (US$/kg) Table 175. China Nifedipine Sales Price by Type (2027-2032) & (US$/kg) Table 176. China Nifedipine Revenue by Application (2021-2026) & (US$ Million) Table 177. China Nifedipine Revenue by Application (2027-2032) & (US$ Million) Table 178. China Nifedipine Sales by Application (2021-2026) & (tons) Table 179. China Nifedipine Sales by Application (2027-2032) & (tons) Table 180. China Nifedipine Sales Price by Application (2021-2026) & (US$/kg) Table 181. China Nifedipine Sales Price by Application (2027-2032) & (US$/kg) Table 182. Asia Nifedipine Revenue by Type (2021-2026) & (US$ Million) Table 183. Asia Nifedipine Revenue by Type (2027-2032) & (US$ Million) Table 184. Asia Nifedipine Sales by Type (2021-2026) & (tons) Table 185. Asia Nifedipine Sales by Type (2027-2032) & (tons) Table 186. Asia Nifedipine Sales Price by Type (2021-2026) & (US$/kg) Table 187. Asia Nifedipine Sales Price by Type (2027-2032) & (US$/kg) Table 188. Asia Nifedipine Revenue by Application (2021-2026) & (US$ Million) Table 189. Asia Nifedipine Revenue by Application (2027-2032) & (US$ Million) Table 190. Asia Nifedipine Sales by Application (2021-2026) & (tons) Table 191. Asia Nifedipine Sales by Application (2027-2032) & (tons) Table 192. Asia Nifedipine Sales Price by Application (2021-2026) & (US$/kg) Table 193. Asia Nifedipine Sales Price by Application (2027-2032) & (US$/kg) Table 194. Asia Nifedipine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 195. Asia Nifedipine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 196. Asia Nifedipine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 197. Asia Nifedipine Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 198. Asia Nifedipine Sales by Country (2021-2026) & (tons) Table 199. Asia Nifedipine Sales by Country (2027-2032) & (tons) Table 200. Asia Nifedipine Sales Price by Country (2021-2026) & (US$/kg) Table 201. Asia Nifedipine Sales Price by Country (2027-2032) & (US$/kg) Table 202. Japan Nifedipine Revenue (2021-2032) & (US$ Million) Table 203. South Korea Nifedipine Revenue (2021-2032) & (US$ Million) Table 204. India Nifedipine Revenue (2021-2032) & (US$ Million) Table 205. Australia Nifedipine Revenue (2021-2032) & (US$ Million) Table 206. Taiwan Nifedipine Revenue (2021-2032) & (US$ Million) Table 207. Southeast Asia Nifedipine Revenue (2021-2032) & (US$ Million) Table 208. SAMEA Nifedipine Revenue by Type (2021-2026) & (US$ Million) Table 209. SAMEA Nifedipine Revenue by Type (2027-2032) & (US$ Million) Table 210. SAMEA Nifedipine Sales by Type (2021-2026) & (tons) Table 211. SAMEA Nifedipine Sales by Type (2027-2032) & (tons) Table 212. SAMEA Nifedipine Sales Price by Type (2021-2026) & (US$/kg) Table 213. SAMEA Nifedipine Sales Price by Type (2027-2032) & (US$/kg) Table 214. SAMEA Nifedipine Revenue by Application (2021-2026) & (US$ Million) Table 215. SAMEA Nifedipine Revenue by Application (2027-2032) & (US$ Million) Table 216. SAMEA Nifedipine Sales by Application (2021-2026) & (tons) Table 217. SAMEA Nifedipine Sales by Application (2027-2032) & (tons) Table 218. SAMEA Nifedipine Sales Price by Application (2021-2026) & (US$/kg) Table 219. SAMEA Nifedipine Sales Price by Application (2027-2032) & (US$/kg) Table 220. SAMEA Nifedipine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 221. SAMEA Nifedipine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 222. SAMEA Nifedipine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 223. SAMEA Nifedipine Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 224. SAMEA Nifedipine Sales by Country (2021-2026) & (tons) Table 225. SAMEA Nifedipine Sales by Country (2027-2032) & (tons) Table 226. SAMEA Nifedipine Sales Price by Country (2021-2026) & (US$/kg) Table 227. SAMEA Nifedipine Sales Price by Country (2027-2032) & (US$/kg) Table 228. Brazil Nifedipine Revenue (2021-2032) & (US$ Million) Table 229. Argentina Nifedipine Revenue (2021-2032) & (US$ Million) Table 230. Chile Nifedipine Revenue (2021-2032) & (US$ Million) Table 231. Colombia Nifedipine Revenue (2021-2032) & (US$ Million) Table 232. Peru Nifedipine Revenue (2021-2032) & (US$ Million) Table 233. Saudi Arabia Nifedipine Revenue (2021-2032) & (US$ Million) Table 234. Israel Nifedipine Revenue (2021-2032) & (US$ Million) Table 235. UAE Nifedipine Revenue (2021-2032) & (US$ Million) Table 236. Turkey Nifedipine Revenue (2021-2032) & (US$ Million) Table 237. Iran Nifedipine Revenue (2021-2032) & (US$ Million) Table 238. Egypt Nifedipine Revenue (2021-2032) & (US$ Million) Table 239. Key Raw Materials Table 240. Raw Materials Key Suppliers Table 241. Nifedipine Distributors List Table 242. Nifedipine Customers List Table 243. Research Programs/Design for This Report Table 244. Authors List of This Report Table 245. Secondary Sources Table 246. Primary Sources List of Figures Figure 1. Nifedipine Image Figure 2. Global Nifedipine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nifedipine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Nifedipine Controlled Release Tablets Image Figure 5. Nifedipine Extended Action Tablets Image Figure 6. Global Nifedipine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Nifedipine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hypertension Image Figure 9. Heart Disease Image Figure 10. Other Image Figure 11. Global Nifedipine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Nifedipine Revenue (2021-2032) & (US$ Million) Figure 13. Global Nifedipine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Nifedipine Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Nifedipine Revenue Market Share by Region (2021-2032) Figure 16. Global Nifedipine Sales (2021-2032) & (tons) Figure 17. Global Nifedipine Sales by Region: 2021 VS 2025 VS 2032 (tons) Figure 18. Global Nifedipine Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Nifedipine Sales YoY (2021-2032) & (tons) Figure 20. Europe Nifedipine Sales YoY (2021-2032) & (tons) Figure 21. China Nifedipine Sales YoY (2021-2032) & (tons) Figure 22. Asia (Excluding China) Nifedipine Sales YoY (2021-2032) & (tons) Figure 23. South America, Middle East and Africa Nifedipine Sales YoY (2021-2032) & (tons) Figure 24. Global Nifedipine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Nifedipine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Nifedipine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Nifedipine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Nifedipine Revenue Market Share by Type (2021-2032) Figure 30. Global Nifedipine Sales by Type (2021 VS 2025 VS 2032) & (tons) Figure 31. Global Nifedipine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Nifedipine Sales Market Share by Type (2021-2032) Figure 33. Global Nifedipine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Nifedipine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Nifedipine Revenue Market Share by Application (2021-2032) Figure 36. Global Nifedipine Sales by Application (2021 VS 2025 VS 2032) & (tons) Figure 37. Global Nifedipine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Nifedipine Sales Market Share by Application (2021-2032) Figure 39. North America Nifedipine Revenue Share by Type (2021-2032) Figure 40. North America Nifedipine Sales Share by Type (2021-2032) Figure 41. North America Nifedipine Revenue Share by Application (2021-2032) Figure 42. North America Nifedipine Sales Share by Application (2021-2032) Figure 43. North America Nifedipine Revenue Share by Country (2021-2032) Figure 44. North America Nifedipine Sales Share by Country (2021-2032) Figure 45. Europe Nifedipine Revenue Share by Type (2021-2032) Figure 46. Europe Nifedipine Sales Share by Type (2021-2032) Figure 47. Europe Nifedipine Revenue Share by Application (2021-2032) Figure 48. Europe Nifedipine Sales Share by Application (2021-2032) Figure 49. Europe Nifedipine Revenue Share by Country (2021-2032) Figure 50. Europe Nifedipine Sales Share by Country (2021-2032) Figure 51. China Nifedipine Revenue Share by Type (2021-2032) Figure 52. China Nifedipine Sales Share by Type (2021-2032) Figure 53. China Nifedipine Revenue Share by Application (2021-2032) Figure 54. China Nifedipine Sales Share by Application (2021-2032) Figure 55. Asia Nifedipine Revenue Share by Type (2021-2032) Figure 56. Asia Nifedipine Sales Share by Type (2021-2032) Figure 57. Asia Nifedipine Revenue Share by Application (2021-2032) Figure 58. Asia Nifedipine Sales Share by Application (2021-2032) Figure 59. Asia Nifedipine Revenue Share by Country (2021-2032) Figure 60. Asia Nifedipine Sales Share by Country (2021-2032) Figure 61. SAMEA Nifedipine Revenue Share by Type (2021-2032) Figure 62. SAMEA Nifedipine Sales Share by Type (2021-2032) Figure 63. SAMEA Nifedipine Revenue Share by Application (2021-2032) Figure 64. SAMEA Nifedipine Sales Share by Application (2021-2032) Figure 65. SAMEA Nifedipine Revenue Share by Country (2021-2032) Figure 66. SAMEA Nifedipine Sales Share by Country (2021-2032) Figure 67. Nifedipine Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Nifedipine Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Nifedipine Controlled Release Tablets
  • Nifedipine Extended Action Tablets
Applications
  • Hypertension
  • Heart Disease
  • Other
Companies covered
  • Actavis
  • Bayer
  • Honglin Pharmaceutical
  • Huanghai
  • Pfizer
  • Lifeon Pharmaceutical
  • Teva
  • Simcere
  • Shyndec
  • Yabao
  • ApicHope
  • EASEHEAL Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Nifedipine Market by Type
  3. 1.2.1 Global Nifedipine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Nifedipine Controlled Release Tablets
  5. 1.2.3 Nifedipine Extended Action Tablets
  6. 1.3 Nifedipine Market by Application
  7. 1.3.1 Global Nifedipine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hypertension
  9. 1.3.3 Heart Disease
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Nifedipine Market Dynamics
  1. 2.1 Nifedipine Industry Trends
  2. 2.2 Nifedipine Industry Drivers
  3. 2.3 Nifedipine Industry Opportunities and Challenges
  4. 2.4 Nifedipine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Nifedipine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Nifedipine Revenue by Region
  3. 3.2.1 Global Nifedipine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Nifedipine Revenue by Region (2021-2026)
  5. 3.2.3 Global Nifedipine Revenue by Region (2027-2032)
  6. 3.2.4 Global Nifedipine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Nifedipine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Nifedipine Sales by Region
  9. 3.4.1 Global Nifedipine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Nifedipine Sales by Region (2021-2026)
  11. 3.4.3 Global Nifedipine Sales by Region (2027-2032)
  12. 3.4.4 Global Nifedipine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Nifedipine Revenue by Manufacturers
  2. 4.1.1 Global Nifedipine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Nifedipine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Nifedipine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Nifedipine Sales by Manufacturers
  6. 4.2.1 Global Nifedipine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Nifedipine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Nifedipine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Nifedipine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Nifedipine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Nifedipine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Nifedipine Manufacturers, Product Type & Application
  13. 4.7 Global Nifedipine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Nifedipine Market CR5 and HHI
  16. 4.8.2 2025 Nifedipine Tier 1, Tier 2, and Tier 3
5 Nifedipine Market by Type
  1. 5.1 Global Nifedipine Revenue by Type
  2. 5.1.1 Global Nifedipine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Nifedipine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Nifedipine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Nifedipine Sales by Type
  6. 5.2.1 Global Nifedipine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Nifedipine Sales by Type (2021-2032) & (tons)
  8. 5.2.3 Global Nifedipine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Nifedipine Price by Type
6 Nifedipine Market by Application
  1. 6.1 Global Nifedipine Revenue by Application
  2. 6.1.1 Global Nifedipine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Nifedipine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Nifedipine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Nifedipine Sales by Application
  6. 6.2.1 Global Nifedipine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Nifedipine Sales by Application (2021-2032) & (tons)
  8. 6.2.3 Global Nifedipine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Nifedipine Price by Application
7 Company Profiles
  1. 7.1 Actavis
  2. 7.1.1 Actavis Company Information
  3. 7.1.2 Actavis Business Overview
  4. 7.1.3 Actavis Nifedipine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Actavis Nifedipine Product Portfolio
  6. 7.1.5 Actavis Recent Developments
  7. 7.2 Bayer
  8. 7.2.1 Bayer Company Information
  9. 7.2.2 Bayer Business Overview
  10. 7.2.3 Bayer Nifedipine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Bayer Nifedipine Product Portfolio
  12. 7.2.5 Bayer Recent Developments
  13. 7.3 Honglin Pharmaceutical
  14. 7.3.1 Honglin Pharmaceutical Company Information
  15. 7.3.2 Honglin Pharmaceutical Business Overview
  16. 7.3.3 Honglin Pharmaceutical Nifedipine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Honglin Pharmaceutical Nifedipine Product Portfolio
  18. 7.3.5 Honglin Pharmaceutical Recent Developments
  19. 7.4 Huanghai
  20. 7.4.1 Huanghai Company Information
  21. 7.4.2 Huanghai Business Overview
  22. 7.4.3 Huanghai Nifedipine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Huanghai Nifedipine Product Portfolio
  24. 7.4.5 Huanghai Recent Developments
  25. 7.5 Pfizer
  26. 7.5.1 Pfizer Company Information
  27. 7.5.2 Pfizer Business Overview
  28. 7.5.3 Pfizer Nifedipine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Pfizer Nifedipine Product Portfolio
  30. 7.5.5 Pfizer Recent Developments
  31. 7.6 Lifeon Pharmaceutical
  32. 7.6.1 Lifeon Pharmaceutical Company Information
  33. 7.6.2 Lifeon Pharmaceutical Business Overview
  34. 7.6.3 Lifeon Pharmaceutical Nifedipine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Lifeon Pharmaceutical Nifedipine Product Portfolio
  36. 7.6.5 Lifeon Pharmaceutical Recent Developments
  37. 7.7 Teva
  38. 7.7.1 Teva Company Information
  39. 7.7.2 Teva Business Overview
  40. 7.7.3 Teva Nifedipine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Teva Nifedipine Product Portfolio
  42. 7.7.5 Teva Recent Developments
  43. 7.8 Simcere
  44. 7.8.1 Simcere Company Information
  45. 7.8.2 Simcere Business Overview
  46. 7.8.3 Simcere Nifedipine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Simcere Nifedipine Product Portfolio
  48. 7.8.5 Simcere Recent Developments
  49. 7.9 Shyndec
  50. 7.9.1 Shyndec Company Information
  51. 7.9.2 Shyndec Business Overview
  52. 7.9.3 Shyndec Nifedipine Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Shyndec Nifedipine Product Portfolio
  54. 7.9.5 Shyndec Recent Developments
  55. 7.10 Yabao
  56. 7.10.1 Yabao Company Information
  57. 7.10.2 Yabao Business Overview
  58. 7.10.3 Yabao Nifedipine Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Yabao Nifedipine Product Portfolio
  60. 7.10.5 Yabao Recent Developments
  61. 7.11 ApicHope
  62. 7.11.1 ApicHope Company Information
  63. 7.11.2 ApicHope Business Overview
  64. 7.11.3 ApicHope Nifedipine Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 ApicHope Nifedipine Product Portfolio
  66. 7.11.5 ApicHope Recent Developments
  67. 7.12 EASEHEAL Pharmaceutical
  68. 7.12.1 EASEHEAL Pharmaceutical Company Information
  69. 7.12.2 EASEHEAL Pharmaceutical Business Overview
  70. 7.12.3 EASEHEAL Pharmaceutical Nifedipine Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 EASEHEAL Pharmaceutical Nifedipine Product Portfolio
  72. 7.12.5 EASEHEAL Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Nifedipine Market Size by Type
  2. 8.1.1 North America Nifedipine Revenue by Type (2021-2032)
  3. 8.1.2 North America Nifedipine Sales by Type (2021-2032)
  4. 8.1.3 North America Nifedipine Price by Type (2021-2032)
  5. 8.2 North America Nifedipine Market Size by Application
  6. 8.2.1 North America Nifedipine Revenue by Application (2021-2032)
  7. 8.2.2 North America Nifedipine Sales by Application (2021-2032)
  8. 8.2.3 North America Nifedipine Price by Application (2021-2032)
  9. 8.3 North America Nifedipine Market Size by Country
  10. 8.3.1 North America Nifedipine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Nifedipine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Nifedipine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Nifedipine Market Size by Type
  2. 9.1.1 Europe Nifedipine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Nifedipine Sales by Type (2021-2032)
  4. 9.1.3 Europe Nifedipine Price by Type (2021-2032)
  5. 9.2 Europe Nifedipine Market Size by Application
  6. 9.2.1 Europe Nifedipine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Nifedipine Sales by Application (2021-2032)
  8. 9.2.3 Europe Nifedipine Price by Application (2021-2032)
  9. 9.3 Europe Nifedipine Market Size by Country
  10. 9.3.1 Europe Nifedipine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Nifedipine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Nifedipine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Nifedipine Market Size by Type
  2. 10.1.1 China Nifedipine Revenue by Type (2021-2032)
  3. 10.1.2 China Nifedipine Sales by Type (2021-2032)
  4. 10.1.3 China Nifedipine Price by Type (2021-2032)
  5. 10.2 China Nifedipine Market Size by Application
  6. 10.2.1 China Nifedipine Revenue by Application (2021-2032)
  7. 10.2.2 China Nifedipine Sales by Application (2021-2032)
  8. 10.2.3 China Nifedipine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Nifedipine Market Size by Type
  2. 11.1.1 Asia Nifedipine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Nifedipine Sales by Type (2021-2032)
  4. 11.1.3 Asia Nifedipine Price by Type (2021-2032)
  5. 11.2 Asia Nifedipine Market Size by Application
  6. 11.2.1 Asia Nifedipine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Nifedipine Sales by Application (2021-2032)
  8. 11.2.3 Asia Nifedipine Price by Application (2021-2032)
  9. 11.3 Asia Nifedipine Market Size by Country
  10. 11.3.1 Asia Nifedipine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Nifedipine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Nifedipine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Nifedipine Market Size by Type
  2. 12.1.1 SAMEA Nifedipine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Nifedipine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Nifedipine Price by Type (2021-2032)
  5. 12.2 SAMEA Nifedipine Market Size by Application
  6. 12.2.1 SAMEA Nifedipine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Nifedipine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Nifedipine Price by Application (2021-2032)
  9. 12.3 SAMEA Nifedipine Market Size by Country
  10. 12.3.1 SAMEA Nifedipine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Nifedipine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Nifedipine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Nifedipine Value Chain Analysis
  2. 13.1.1 Nifedipine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Nifedipine Production Mode & Process
  6. 13.2 Nifedipine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Nifedipine Distributors
  9. 13.2.3 Nifedipine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst